Cargando…

Medication adherence in HIV-positive patients with diabetes or hypertension: a focus group study

BACKGROUND: People with HIV are living longer with potent antiretroviral therapy (ART), and HIV is increasingly complicated by other chronic medical comorbidities. The objective of this study was to explore HIV-positive patients’ perspectives on living with HIV and diabetes mellitus (DM) or hyperten...

Descripción completa

Detalles Bibliográficos
Autores principales: Monroe, Anne K, Rowe, Tashi L, Moore, Richard D, Chander, Geetanjali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907021/
https://www.ncbi.nlm.nih.gov/pubmed/24274688
http://dx.doi.org/10.1186/1472-6963-13-488
_version_ 1782301555428425728
author Monroe, Anne K
Rowe, Tashi L
Moore, Richard D
Chander, Geetanjali
author_facet Monroe, Anne K
Rowe, Tashi L
Moore, Richard D
Chander, Geetanjali
author_sort Monroe, Anne K
collection PubMed
description BACKGROUND: People with HIV are living longer with potent antiretroviral therapy (ART), and HIV is increasingly complicated by other chronic medical comorbidities. The objective of this study was to explore HIV-positive patients’ perspectives on living with HIV and diabetes mellitus (DM) or hypertension (HTN) and factors affecting medication adherence. METHODS: We conducted six focus groups. Two investigators independently coded transcripts for thematic content using editing style analysis. Codes were grouped into conceptual themes using consensus process. RESULTS: Thirty-five HIV-positive patients with diabetes or hypertension participated. Four major themes emerged: (1) Comorbidities are a source of concern and frustration, sometimes eclipsing concern regarding HIV (2) Understanding of health conditions and medications promotes adherence, (3) Simpler regimens with fewer side effects promote adherence, and (4) Untreated substance abuse and mental health issues hinder adherence. CONCLUSIONS: HIV-positive patients in this study voiced concern regarding medical comorbidities and highlighted patient understanding, regimen factors, and substance abuse/mental health issues as barriers to adherence. Addressing these issues may improve outcomes in the aging HIV-positive population. Adherence to medications among HIV-positive patients with DM or HTN may be influenced by providing targeted disease-specific education, simplifying regimens, and treatment of substance abuse/mental health issues.
format Online
Article
Text
id pubmed-3907021
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39070212014-01-31 Medication adherence in HIV-positive patients with diabetes or hypertension: a focus group study Monroe, Anne K Rowe, Tashi L Moore, Richard D Chander, Geetanjali BMC Health Serv Res Research Article BACKGROUND: People with HIV are living longer with potent antiretroviral therapy (ART), and HIV is increasingly complicated by other chronic medical comorbidities. The objective of this study was to explore HIV-positive patients’ perspectives on living with HIV and diabetes mellitus (DM) or hypertension (HTN) and factors affecting medication adherence. METHODS: We conducted six focus groups. Two investigators independently coded transcripts for thematic content using editing style analysis. Codes were grouped into conceptual themes using consensus process. RESULTS: Thirty-five HIV-positive patients with diabetes or hypertension participated. Four major themes emerged: (1) Comorbidities are a source of concern and frustration, sometimes eclipsing concern regarding HIV (2) Understanding of health conditions and medications promotes adherence, (3) Simpler regimens with fewer side effects promote adherence, and (4) Untreated substance abuse and mental health issues hinder adherence. CONCLUSIONS: HIV-positive patients in this study voiced concern regarding medical comorbidities and highlighted patient understanding, regimen factors, and substance abuse/mental health issues as barriers to adherence. Addressing these issues may improve outcomes in the aging HIV-positive population. Adherence to medications among HIV-positive patients with DM or HTN may be influenced by providing targeted disease-specific education, simplifying regimens, and treatment of substance abuse/mental health issues. BioMed Central 2013-11-25 /pmc/articles/PMC3907021/ /pubmed/24274688 http://dx.doi.org/10.1186/1472-6963-13-488 Text en Copyright © 2013 Monroe et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Monroe, Anne K
Rowe, Tashi L
Moore, Richard D
Chander, Geetanjali
Medication adherence in HIV-positive patients with diabetes or hypertension: a focus group study
title Medication adherence in HIV-positive patients with diabetes or hypertension: a focus group study
title_full Medication adherence in HIV-positive patients with diabetes or hypertension: a focus group study
title_fullStr Medication adherence in HIV-positive patients with diabetes or hypertension: a focus group study
title_full_unstemmed Medication adherence in HIV-positive patients with diabetes or hypertension: a focus group study
title_short Medication adherence in HIV-positive patients with diabetes or hypertension: a focus group study
title_sort medication adherence in hiv-positive patients with diabetes or hypertension: a focus group study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907021/
https://www.ncbi.nlm.nih.gov/pubmed/24274688
http://dx.doi.org/10.1186/1472-6963-13-488
work_keys_str_mv AT monroeannek medicationadherenceinhivpositivepatientswithdiabetesorhypertensionafocusgroupstudy
AT rowetashil medicationadherenceinhivpositivepatientswithdiabetesorhypertensionafocusgroupstudy
AT moorerichardd medicationadherenceinhivpositivepatientswithdiabetesorhypertensionafocusgroupstudy
AT chandergeetanjali medicationadherenceinhivpositivepatientswithdiabetesorhypertensionafocusgroupstudy